Advanced breast cancer: an update and controversies on diagnosis and therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference76 articles.
1. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial;Nabholtz;J Clin Oncol,2000
2. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or arimidex randomized group efficacy and tolerability study;Bonneterre;J Clin Oncol,2000
3. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma;Bonneterre;Cancer,2001
4. Comparison of toremifene and tamoxifen in postmenopausal patients with advanced breast cancer: a randomised double blind, the “Nordic” Phase III Study;Pyrhonen;Br J Cancer,1997
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer;Breast Cancer Research and Treatment;2024-01-06
2. Micro/Nanorobots for Medical Diagnosis and Disease Treatment;Micromachines;2022-04-19
3. Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer;Journal of Drug Delivery Science and Technology;2020-06
4. Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment;Technology in Cancer Research & Treatment;2018-01
5. Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells;Biomedicine & Pharmacotherapy;2014-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3